Splunk Inc (SPLK) 61.07 $SPLK The 3 Non-Retail Earnings

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Splunk Inc (SPLK) 61.07 $SPLK

The 3 Non-Retail Earnings Reports That Investors Will Want to Pay Attention to This Week
ESTMZ - 2 hrs 57 mins ago
It’s easy to get lost in a sea of retail results this week, but there are several smaller software and internet companies that have notable Estimize/Wall Street deltas, and warrant investor attention. Look out for the names below as they report...
WDAY: 80.50 (-0.09), SPLK: 61.07 (+1.04), CTRP: 92.89 (-4.50)

Splunk Is About to Spring Higher
at The Street - Tue Nov 17, 6:02AM CST
Splunk has formed a rounded bottom base, and a breakout from the pattern targets a 15% gain.
SPLK: 61.07 (+1.04)

What to Expect When Splunk Inc. Reports Earnings
Steve Symington, The Motley Fool - Motley Fool - Mon Nov 16, 8:12PM CST
Credit: Splunk. Splunk is set to release third-quarter fiscal 2016 results this Thursday after the bell. With shares of the operational-intelligence specialist down roughly 14% over the past three months as of this writing, it's time for...
SPLK: 61.07 (+1.04)

Splunk Q3 Seen Barely In Black; Will Revenue Beat?
at Investor's Business Daily - Mon Nov 16, 4:25PM CST
Sometimes fast but hard-fought gains are followed by hard-fought deceleration. That could be the case for Splunk (SPLK), which reports its third-quarter earnings after the close Thursday. The data analytics company typically is right near the...
SPLK: 61.07 (+1.04), DATA: 93.48 (+0.96), ORCL: 38.40 (+0.28)

What to Expect from Splunk (SPLK) in Q3 Earnings Release?
Zacks Equity Research - Zacks Investment Research - Mon Nov 16, 10:30AM CST
Splunk Inc. (SPLK) is scheduled to release third-quarter fiscal 2016 results on Nov 19.
IBM: 133.71 (unch), ANF: 18.76 (-0.77), SPLK: 61.07 (+1.04), ORCL: 38.40 (+0.28)

ServiceNow Growing As Customers Look To Streamline
at Investor's Business Daily - Fri Nov 13, 4:27PM CST
The days of workers relying on office email to get their jobs done are far from over, but ServiceNow is developing a new generation of products it says provide more efficient ways for workers to communicate. Take the example of storage company...
AMZN: 646.37 (-1.44), ADP: 85.91 (-0.61), SAP: 78.30 (+0.27), NOW: 85.16 (+0.79), WDAY: 80.50 (-0.09), SPLK: 61.07 (+1.04), NTAP: 31.49 (unch), MSFT: 53.11 (-0.65), HPE: 13.23 (-0.15), CRM: 77.70 (+1.44)

Splunk stock rose
at Investor's Business Daily - Thu Nov 12, 5:45PM CST
Splunk (SPLK) stock rose 2.8% to 58.78 on positive comments from JMP Securities ahead of the Big Data firm's earnings on Nov. 19.
SPLK: 61.07 (+1.04)

Splunk Delivers Security Analytics and Threat Prevention to Integra Customers
Business Wire - Tue Nov 10, 7:00AM CST
Splunk Inc. (NASDAQ:SPLK), provider of the leading software platform for real-time Operational Intelligence, today announced Splunk(R) Enterprise and Splunk Enterprise Security (ES) are at the heart of an expanded security operations center (SOC) for Integra. Integra's SOC is utilizing Splunk ES to detect, prevent and respond to attacks, and to provide customers with 24/7 security analysis for the Integra network and services. Integra is also using Splunk Enterprise to enhance its operations in ways that will deliver significant benefits to customers.
SPLK: 61.07 (+1.04)

Splunk CTO Snehal Antani Named to Computerworld's 2016 Premier 100 Technology Leaders
Business Wire - Mon Nov 09, 7:00AM CST
Splunk Inc. (NASDAQ:SPLK), provider of the leading software platform for real-time Operational Intelligence, today announced Snehal Antani, chief technology officer, Splunk, has been named as a 2016 Premier 100 Technology Leader by IDG's Computerworld. This year's Premier 100 spotlights 100 leaders from both the technology and business sides of organizations for their exceptional technology leadership and innovative approaches to business challenges.
SPLK: 61.07 (+1.04)

FireEye: Is the Selling Deluge Overdone?
Asit Sharma, The Motley Fool - Motley Fool - Sat Nov 07, 11:01AM CST
The stock of FireEye Inc.  spent the first part of this year scrambling up its price chart to a near 75% gain through the middle of June. In the handful of months since, however, shares have simply collapsed. Including the Q3 2015 post-earnings...
FEYE: 21.78 (-0.69), SPLK: 61.07 (+1.04), PANW: 162.79 (+4.04)

Customers Flock To Tableau, Investors To Its Stock
at Investor's Business Daily - Fri Nov 06, 2:10PM CST
Treated to 64% revenue growth in the third quarter, shareholders bid up Tableau Software (DATA) stock Friday, boosting the IBD Computer Software-Database industry group. Shares of Splunk (SPLK), a Tableau customer and competitor, were up 9.5% in...
AMZN: 646.37 (-1.44), QLIK: 31.24 (+0.07), CS: 23.09 (-0.05), TGT: 73.15 (+0.84), SPLK: 61.07 (+1.04), DATA: 93.48 (+0.96), ACN: 106.67 (+0.34), CMCSA: 61.30 (-0.05), CSCO: 26.97 (+0.18)

Federal Realty Investment Trust Announces Third Quarter 2015 Operating Results
PR Newswire - Wed Nov 04, 3:10PM CST
Federal Realty Investment Trust (NYSE: FRT) today reported operating results for its third quarter ended September 30, 2015. Highlights of the quarter and recent activity include:
FRT: 144.96 (+1.45), SPLK: 61.07 (+1.04)

CanDeal Standardizes on Splunk Enterprise as Its Platform for Security Intelligence
Business Wire - Wed Nov 04, 7:00AM CST
Splunk Inc. (NASDAQ:SPLK), provider of the leading software platform for real-time Operational Intelligence, today announced that CanDeal, the leading institutional electronic marketplace for Canadian bond, money market and derivatives trading, has implemented Splunk(R) Enterprise and Splunk Enterprise Security for security analytics across its IT infrastructure. Splunk Enterprise helps enable CanDeal to quickly and easily mitigate advanced persistent threats (APTs) and meet a wide range of industry and security regulations. The financial marketplace is also using the Splunk App for Stream to improve overall workflow, increase operational efficiencies and gain insights from network wire data. To learn more, read the CanDeal case study on the Splunk website.
SPLK: 61.07 (+1.04)

Splunk to Announce Fiscal Third Quarter 2016 Results on November 19, 2015
Business Wire - Tue Nov 03, 7:00AM CST
Splunk Inc. (NASDAQ:SPLK), provider of the leading software platform for real-time Operational Intelligence, will report results for its fiscal third quarter ended October 31, 2015 on Thursday, November 19, 2015. The results will be included in a press release with accompanying financial information that will be released after market close and posted on the Splunk Investor Relations website.
SPLK: 61.07 (+1.04)

Splunk Enterprise Security 4.0, Splunk UBA and the Splunk App for PCI Compliance 3.0 Now Generally Available
Business Wire - Tue Oct 27, 7:00AM CDT
Splunk Inc. (NASDAQ:SPLK), provider of the leading software platform for real-time Operational Intelligence, today announced the general availability of Splunk Enterprise Security 4.0 (ES), Splunk User Behavior Analytics (UBA) and the Splunk App for PCI Compliance 3.0. Splunk(R) ES includes major updates to help organizations track attackers' actions with streamlined ad hoc analyses and event sequencing. Splunk UBA delivers out-of-the-box capabilities driven by machine learning and advanced analytics to help detect cyberattacks and insider threats. The Splunk App for PCI Compliance helps organizations verify their compliance to the Payment Card Industry Data Security Standards (PCI DSS). Contact Splunk to purchase Splunk ES, Splunk UBA or the Splunk App for PCI Compliance for on-premises, hybrid or cloud environments.
SPLK: 61.07 (+1.04)

Why Qlik Technologies Inc. Fell on Friday
Anders Bylund, The Motley Fool - Motley Fool - Fri Oct 23, 2:33PM CDT
Source: Qlik. What: Shares of Qlik Technologies fell as much as 13.2% in Friday's trading session. The maker of data analysis and visualization tools reported third-quarter results on Thursday night, falling short of Wall Street's revenue...
QLIK: 31.24 (+0.07), SPLK: 61.07 (+1.04), DATA: 93.48 (+0.96)

Will Amazon.com Inc. Disrupt Tableau, Splunk, and Qlik Technologies?
Andrew Tonner, The Motley Fool - Motley Fool - Wed Oct 21, 5:15PM CDT
Source: Amazon.com. Although several of big tech's most powerful names deserve consideration, e-commerce-turned-everything provider Amazon.com gets my vote as the most lethal competitor in all of tech. Software vendors focused on business...
AMZN: 646.57 (-1.24), QLIK: 31.24 (+0.07), SPLK: 61.07 (+1.04), DATA: 93.48 (+0.96)

Booz Allen Hamilton and Splunk Announce Strategic Alliance to Deliver Predictive Security Analytics and Operationalize Threat Intelligence
M2 - Mon Oct 19, 4:09AM CDT
* New Alliance Enables Booz Allen Hamilton to Extend Splunk Security Solutions to a Larger Audience
BAH: 29.13 (-0.08), SPLK: 61.07 (+1.04)

Rapid7 Buys Logentries To Enhance Data Analytics
at Investor's Business Daily - Wed Oct 14, 11:32AM CDT
Data security and analytics company Rapid7 (RPD) will acquire Logentries, a provider of machine data search technology, for $68 million. But investors weren't thrilled. Logentries has a cloud-based platform that can search and analyze computer...
FEYE: 21.78 (-0.69), RPD: 20.90 (+0.69), CYBR: 37.97 (-0.67), SPLK: 61.07 (+1.04), PANW: 162.79 (+4.04)

The Zacks Analyst Blog Highlights: Qualys, Splunk, ServiceNow, SkyWest and USA Compression Partners
Zacks Equity Research - Zacks Investment Research - Wed Oct 14, 8:30AM CDT
The Zacks Analyst Blog Highlights: Qualys, Splunk, ServiceNow, SkyWest and USA Compression Partners
SKYW: 19.70 (+0.21), NOW: 85.16 (+0.79), QLYS: 36.15 (+0.04), SPLK: 61.07 (+1.04), USAC: 16.25 (-0.09)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 84

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 21

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 299

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 175

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 98

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Schouw & Co.'s Share Buy-Back Strategy for 2025

Updated Category News Views 153

Overview of Schouw & Co.'s Share Buy-Back Program Schouw & Co. has launched an exciting share buy-back initiative, aiming to enhance shareholder value significantly. This program began on May 5, 2025, and is designed to repurchase shares totaling up to DKK 120 million. This investment runs until December 31, 2025, reflecting the company's commitment to its shareholders....

Continue Reading
Schneider National Plans to Reveal Q3 2024 Earnings Soon

Updated Category News Views 45

Schneider National to Report Third Quarter 2024 Earnings Schneider National, Inc. (NYSE: SNDR), a leader in transportation and logistics services, has announced that it will release its third quarter 2024 earnings report on a future date, ahead of the market opening. This announcement is significant as it highlights the company’s continued focus on financial...

Continue Reading
A Closer Look at BioAge Labs: Legal Challenges Ahead

Updated Category News Views 206

Understanding the Legal Landscape of BioAge Labs Investors in BioAge Labs, Inc. have faced new uncertainties as the clinical-stage biopharmaceutical company becomes entangled in legal challenges. As the firm moves forward in its mission to develop innovative therapies aimed at combating metabolic diseases, significant developments have emerged that every investor should...

Continue Reading
Celebrating the Fusion of Science and Cinema at Starmus 2025

Updated Category News Views 202

Fusion of Science and Cinema at Starmus Festival The Starmus Festival is a unique event that intertwines science and art, culminating in extraordinary dialogues and presentations. Recently, renowned director Christopher Nolan was awarded the prestigious Stephen Hawking Medal for Science Communication during this remarkable celebration. This accolade is not just an honor...

Continue Reading
Millicom Takes Steps to Enhance Transparency in Holdings

Updated Category News Views 82

Millicom Takes Steps to Enhance Transparency in Holdings Millicom International Cellular S.A., commonly recognized as Tigo, is making significant strides in open communication and compliance by submitting regulatory notifications regarding major shareholder holdings. This initiative reinforces their commitment to transparency and regulatory excellence in the ever-evolving...

Continue Reading